Pfizer lifts earnings guidance, citing revenue from coronavirus vaccine

2 days ago 10

Pfizer Q1 vaccines revenue $4.89 bln vs. $1.61 bln a year ago

May. 4, 2021 at 6:49 a.m. ET by Tomi Kilgore

Pfizer raised 2021 adj. EPS outlook to $3.55-$3.65 from $3.10-$3.20

May. 4, 2021 at 6:48 a.m. ET by Tomi Kilgore

Pfizer Q1 revenue $14.58 bln vs. $10.08 bln a year ago; FactSet consensus $13.54 bln

May. 4, 2021 at 6:47 a.m. ET by Tomi Kilgore

Pfizer Q1 adj. EPS 93 cents; FactSet consensus 77 cents

May. 4, 2021 at 6:47 a.m. ET by Tomi Kilgore

Pfizer Q1 EPS 86 cents vs. 60 cents a year ago

May. 4, 2021 at 6:46 a.m. ET by Tomi Kilgore

Read full story
Read full story

Pfizer Inc. stock rises Monday, outperforms market

May. 3, 2021 at 5:15 p.m. ET by MarketWatch Automation

Read full story
Read full story
Go to video

Stock Summer Swoon Coming?

May. 3, 2021 at 8:02 a.m. ET

Read full story

Pfizer Inc. stock rises Friday, outperforms market

Apr. 30, 2021 at 5:15 p.m. ET by MarketWatch Automation

Read full story
Read full story
Read full story
Read full story
Read Entire Article
Sponsor Ads